IBDEI1O6 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27933,2)
 ;;=^5063759
 ;;^UTILITY(U,$J,358.3,27934,0)
 ;;=A15.0^^132^1322^84
 ;;^UTILITY(U,$J,358.3,27934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27934,1,3,0)
 ;;=3^Tuberculosis of Lung
 ;;^UTILITY(U,$J,358.3,27934,1,4,0)
 ;;=4^A15.0
 ;;^UTILITY(U,$J,358.3,27934,2)
 ;;=^5000062
 ;;^UTILITY(U,$J,358.3,27935,0)
 ;;=B20.^^132^1322^31
 ;;^UTILITY(U,$J,358.3,27935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27935,1,3,0)
 ;;=3^HIV Disease
 ;;^UTILITY(U,$J,358.3,27935,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,27935,2)
 ;;=^5000555
 ;;^UTILITY(U,$J,358.3,27936,0)
 ;;=B02.9^^132^1322^93
 ;;^UTILITY(U,$J,358.3,27936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27936,1,3,0)
 ;;=3^Zoster w/o Complications
 ;;^UTILITY(U,$J,358.3,27936,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,27936,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,27937,0)
 ;;=A60.9^^132^1322^2
 ;;^UTILITY(U,$J,358.3,27937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27937,1,3,0)
 ;;=3^Anogenital Herpesviral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,27937,1,4,0)
 ;;=4^A60.9
 ;;^UTILITY(U,$J,358.3,27937,2)
 ;;=^5000359
 ;;^UTILITY(U,$J,358.3,27938,0)
 ;;=A60.04^^132^1322^34
 ;;^UTILITY(U,$J,358.3,27938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27938,1,3,0)
 ;;=3^Herpesviral Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,27938,1,4,0)
 ;;=4^A60.04
 ;;^UTILITY(U,$J,358.3,27938,2)
 ;;=^5000356
 ;;^UTILITY(U,$J,358.3,27939,0)
 ;;=A60.01^^132^1322^32
 ;;^UTILITY(U,$J,358.3,27939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27939,1,3,0)
 ;;=3^Herpesviral Infection of Penis
 ;;^UTILITY(U,$J,358.3,27939,1,4,0)
 ;;=4^A60.01
 ;;^UTILITY(U,$J,358.3,27939,2)
 ;;=^5000353
 ;;^UTILITY(U,$J,358.3,27940,0)
 ;;=B00.1^^132^1322^33
 ;;^UTILITY(U,$J,358.3,27940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27940,1,3,0)
 ;;=3^Herpesviral Vesicular Dermatitis
 ;;^UTILITY(U,$J,358.3,27940,1,4,0)
 ;;=4^B00.1
 ;;^UTILITY(U,$J,358.3,27940,2)
 ;;=^5000468
 ;;^UTILITY(U,$J,358.3,27941,0)
 ;;=B97.89^^132^1322^89
 ;;^UTILITY(U,$J,358.3,27941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27941,1,3,0)
 ;;=3^Viral Agent Cause of Disease
 ;;^UTILITY(U,$J,358.3,27941,1,4,0)
 ;;=4^B97.89
 ;;^UTILITY(U,$J,358.3,27941,2)
 ;;=^5000879
 ;;^UTILITY(U,$J,358.3,27942,0)
 ;;=B97.10^^132^1322^21
 ;;^UTILITY(U,$J,358.3,27942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27942,1,3,0)
 ;;=3^Enterovirus Cause of Disease
 ;;^UTILITY(U,$J,358.3,27942,1,4,0)
 ;;=4^B97.10
 ;;^UTILITY(U,$J,358.3,27942,2)
 ;;=^5000861
 ;;^UTILITY(U,$J,358.3,27943,0)
 ;;=B34.9^^132^1322^90
 ;;^UTILITY(U,$J,358.3,27943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27943,1,3,0)
 ;;=3^Viral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,27943,1,4,0)
 ;;=4^B34.9
 ;;^UTILITY(U,$J,358.3,27943,2)
 ;;=^5000603
 ;;^UTILITY(U,$J,358.3,27944,0)
 ;;=A69.20^^132^1322^50
 ;;^UTILITY(U,$J,358.3,27944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27944,1,3,0)
 ;;=3^Lyme Disease,Unspec
 ;;^UTILITY(U,$J,358.3,27944,1,4,0)
 ;;=4^A69.20
 ;;^UTILITY(U,$J,358.3,27944,2)
 ;;=^5000375
 ;;^UTILITY(U,$J,358.3,27945,0)
 ;;=A69.22^^132^1322^52
 ;;^UTILITY(U,$J,358.3,27945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27945,1,3,0)
 ;;=3^Neurologic Disorders d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,27945,1,4,0)
 ;;=4^A69.22
 ;;^UTILITY(U,$J,358.3,27945,2)
 ;;=^5000377
 ;;^UTILITY(U,$J,358.3,27946,0)
 ;;=A69.21^^132^1322^51
 ;;^UTILITY(U,$J,358.3,27946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27946,1,3,0)
 ;;=3^Meningitis d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,27946,1,4,0)
 ;;=4^A69.21
 ;;^UTILITY(U,$J,358.3,27946,2)
 ;;=^5000376
 ;;^UTILITY(U,$J,358.3,27947,0)
 ;;=A69.29^^132^1322^18
